Keyword      Search in       

Contact
Imprint
Privacy Policy
Site Map

RSS Feed News. Your shopping cart.

Google gadget.

GMP News
13/10/2011
 

Activities of the USP Microbiology and Sterility Assurance Expert Committee During the 2005-2010 Revision Cycle

  
Dr Scott VW Sutton from Microbiology Network and member of the MSA Expert Committee and Dr Radhakrishna Tirumalai, Principal Scientific Liaison for the General Chapters and USP Staff Liaison for the MSA Expert Committee published an article about the activities of the Microbiology and Sterility Assurance Expert Committee (MSA EC) of the United States Pharmacopeial Convention (USP) Council of Experts for the 2005–2010 revision cycle.

This cycle involved the completion of several harmonization efforts, including Sterility Tests, Microbial Limits Tests, and the Bacterial Endotoxins Test. In addition, USP continued in its leadership of laboratory practices with informational chapters (both new and revised) in several areas of laboratory activity. The EC had 9 new general chapters under development and managed 7 monographs, 3 of which were new this cycle. In addition to reviewing the changes accomplished, this article discusses the rationale for many of the changes and some background information about new initiatives now underway. Where appropriate, the authors discuss changes in USP that did not fall under the direct purview of the MSA EC (whose responsibility included 7 monographs and 37 general chapters) but are of interest to the microbiology community.

Please see the article "Activities of the USP Microbiology and Sterility Assurance Expert Committee During the 2005–2010 Revision Cycle" for further details.

Author
Axel H. Schroeder
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)

Related GMP News
21/05/2012New Homepage of ECA's Rapid Microbiological Methods Working Group
21/05/2012Pre-Announcement of ECA's Rapid Microbiological Methods Conference
21/05/2012Case Study of New Growth-based Rapid Microbiological Method (RMM) detects the Presence of Specific Organisms
15/02/2012Overview of FDA Warning Letters regarding the Manufacture of Sterile Medicinal Products
12/01/2012EMA, CVMP - Testing of Mycoplasma Contamination